Breast Hypertrophy Induced by Ombitasvir/Paritaprevir/Ritonavir and Ribavirina

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The breast journal 2016-11, Vol.22 (6), p.708-709
Hauptverfasser:	Gentili, Marta, Magni, Carlo, Carnovale, Carla, Bolis, Matteo, Landonio, Simona, Niero, Fosca, Antoniazzi, Stefania, Clementi, Emilio, Radice, Sonia
Format:	Artikel
Sprache:	eng
Schlagworte:	Anilides - adverse effects Anilides - therapeutic use Antiviral Agents - adverse effects Antiviral Agents - therapeutic use Breast Diseases - chemically induced Carbamates - adverse effects Carbamates - therapeutic use Drug Therapy, Combination - adverse effects Female Hepatitis C - drug therapy Humans Hypertrophy - chemically induced Macrocyclic Compounds - adverse effects Macrocyclic Compounds - therapeutic use Middle Aged Ribavirin - adverse effects Ribavirin - therapeutic use Ritonavir - adverse effects Ritonavir - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!